Learn about the use of imaging, biomarkers, and artificial intelligence (AI) in the diagnosis and management of age-related macular degeneration (AMD) and geographic atrophy (GA).
This free webinar will focus on recognising high-risk biomarkers, understanding differential diagnoses, and leveraging advanced diagnostic equipment such as optical coherence tomography (OCT), fundus autofluorescence (FAF), and retinal photography, to improve patient care.
The webinar will open with Associate Professor Anthony Kwan, followed by optometrists Inez Hsing and Professor James Armitage, who will share their real-world insights through case-based discussions, offering practical strategies and examples to help stay at the forefront of GA diagnosis and management.
It has been accredited by Optometry Australia for 2T Institute of Excellence Quality Assured CPD hours, and by Optometrists and Dispensing Opticians Board (ODOB) for 2G CPD in New Zealand.
Real-World Insights, Practical Strategies
Participants will gain a comprehensive understanding of multimodal imaging techniques used to assess and monitor AMD and GA, including the advantages and limitations of each modality. The program will build confidence in interpreting diagnostic test results and identifying structural biomarkers that may predict disease progression. Additionally, the webinar will touch on practical approaches to supporting AMD patients, including suggested indicators that may prompt more regular review and/or consideration of ophthalmology referral. It will also explore key considerations in differential diagnoses for GA.
The session will also highlight the role of AI and machine learning in enhancing diagnostic assistance and image analysis. Attendees will learn about practical applications of AI-driven tools, how these technologies can be evaluated for clinical use, and strategies for integrating them into existing clinical reasoning frameworks to support decision-making and optimise patient management.
Register Now
Advancing Geographic Atrophy Diagnosis: Imaging, Biomarkers and AI in Clinical Practice will take place on 11 March 2026 at 7pm AEDT (6pm Brisbane time).
About the Speakers
Assoc Prof Anthony Kwan is a vitreoretinal surgeon, retinal specialist and the Director of Vitreoretinal Service at the Queensland Eye Institute, Brisbane. He received his schooling and medical training in England, and ophthalmology training in London. He spent over 10 years at Moorfields Eye Hospital, London, where he also obtained his postgraduate degree, Doctor of Medicine (MD), in retinal transplantation from the Institute of Ophthalmology (the University of London). He obtained his retinal fellowship training in London and Perth.
Assoc Prof Kwan is a senior staff specialist and the former Head of Ophthalmology at Mater Hospital, Brisbane. He was also a past chairperson of the Australian and New Zealand Society of Retinal Specialists (ANZSRS). He is a member of the medical committee of the Macular Disease Foundation Australia (MDFA). In 2020, Assoc Prof Kwan was appointed to the chair of the Macular Disease Foundation Australia’s research committee. He holds the academic title of Associate Professor of Ophthalmology from the University of Queensland. He received grants from the Wellcome Trust and Medical Research Council (MRC) in the UK, and from the Ophthalmic Research Institute of Australia, MDFA, and the National Health and Medical Research Council (NHMRC) in Australia. He teaches medical students and ophthalmic trainees at the Mater Hospital, and is a training post inspector for the Royal Australian and New Zealand College of Ophthalmologists (RANZCO). He is on the advisory board of numerous pharmaceutical companies and is an active organiser for national and international ophthalmic meetings.
Inez Hsing graduated from Queensland University of Technology (QUT) with first class honours and a University Medal. She was also awarded the Optometry Australia Qld/NT Clinical Excellence Award, and completed a Graduate Certificate in Ocular Therapeutics in 2013. Ms Hsing is based at the OKKO Eye Specialist Centre in Brisbane and has over 10 years of experience providing care to patients with macular disease, including collaborative care of AMD patients and assisting in intravitreal injection clinics. Ms Hsing is a clinical supervisor and guest lecturer in the QUT School of Optometry’s Primary Care and Glaucoma clinics.
James Armitage BOptom, CertOcTher (ACO), MOptom, PhD, FACO, FAAO, OACAP-G is a Professor of Optometry and Associate Head of School (International and Partnerships) in the Deakin University School of Medicine. Prof Armitage trained in optometry at the University of Melbourne then undertook postdoctoral fellowships at King’s College London, The Baker Heart and Diabetes Institute and Monash University. His research interests include optometric education research – particularly focusing on better understanding how to improve the way students develop and refine their metacognitive processes to promote safe and efficient clinical reasoning. He is an active clinician and has primary clinical and research interests in managing dry eye disease, glaucoma, and the ocular sequelae of metabolic disease. Prof Armitage’s other research interests include the role of diet in modifying foetal and neonatal development, adult cardiovascular health, and functional studies of ocular vasculature.
